HomeMDXXF • OTCMKTS
add
Pharmala Biotech Holdings Inc
Previous close
$0.084
Day range
$0.097 - $0.11
Year range
$0.040 - $0.26
Market cap
15.40M CAD
Avg Volume
24.23K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | May 2025info | Y/Y change |
---|---|---|
Revenue | 135.17K | -6.48% |
Operating expense | 614.14K | 13.36% |
Net income | -524.24K | -26.89% |
Net profit margin | -387.84 | -35.68% |
Earnings per share | — | — |
EBITDA | -475.47K | -23.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | May 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.25M | 151.16% |
Total assets | 3.63M | 26.45% |
Total liabilities | 876.15K | -0.84% |
Total equity | 2.76M | — |
Shares outstanding | 105.71M | — |
Price to book | 2.80 | — |
Return on assets | -32.41% | — |
Return on capital | -41.77% | — |
Cash Flow
Net change in cash
(CAD) | May 2025info | Y/Y change |
---|---|---|
Net income | -524.24K | -26.89% |
Cash from operations | -257.04K | -14.19% |
Cash from investing | 121.50K | 356.08% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -135.54K | -129.76% |
Free cash flow | -41.35K | 81.05% |
About
Founded
2020
Headquarters
Website